Croda International Public Limited Company
Croda International Public Limited Company
Trading as: Croda
#00206132 • Active
B2bManufacturingPhysical Product
Croda Beauty is dedicated to pioneering smart science that enhances lives through innovative ingredients for the cosmetics and personal care industry. They focus on sustainability and high-performance formulations to meet evolving consumer demands.
Founded: 22/05/1925
Industries: Activities of head offices
Website: https://crodapersonalcare.com
Phone: Subscribe to view
Email: Subscribe to view
Products
- Ds-hydroceramide50™
- Ds-phytosphingosine™
- Luceane™
- Matrixyl™ Range
Services
- Active Ingredients
- Biotechnology
- Botanicals
- Encapsulation
- Fragrances
Financial Snapshot
Last accounts made up to 31 December 2023
Next accounts due 30 June 2025 (1 month)
Cash in Bank £166.8m
↓ -3%
Turnover £1,628.1m
↓ -4%
EBITDA £365.1m
↓ -9%
Gross Profit £869.7m
↓ -1%
Total Liabilities £336.5m
↑ 5%
Employees 6,027
↑ 3%
Directors
Name | Role | Appointed ↓ | Nationality | Age |
|---|---|---|---|---|
| Stephen Richard Oxley | Company Director | 01/04/2025 | British | 54 years |
| Ian Alan Bull | Company Director | 25/06/2024 | British | 64 years |
| Danuta Gray | Company Director | 01/02/2024 | British | 66 years |
| Christopher Good | Non-executive Director | 27/04/2023 | British | 65 years |
| Nawal Ouzren | Chief Executive | 01/02/2022 | French | 47 years |
| Julie So-young Kim | Pharmaceutical Executive | 01/09/2021 | American | 54 years |
| Jacqueline Patricia Christine Ferguson | Director | 01/09/2018 | British | 54 years |
| Roberto Cirillo | General Manager | 26/04/2018 | Swiss | 53 years |
| Keith Layden | Chief Technology Officer | 06/02/2012 | British | 65 years |
| Stephen Edward Foots | Chief Executive | 01/07/2010 | British | 56 years |
Role:
Company Director
Appointed:
01/04/2025
Nationality:
British
Age:
54 years
Role:
Company Director
Appointed:
25/06/2024
Nationality:
British
Age:
64 years
Role:
Company Director
Appointed:
01/02/2024
Nationality:
British
Age:
66 years
Role:
Non-executive Director
Appointed:
27/04/2023
Nationality:
British
Age:
65 years
Role:
Chief Executive
Appointed:
01/02/2022
Nationality:
French
Age:
47 years
Role:
Pharmaceutical Executive
Appointed:
01/09/2021
Nationality:
American
Age:
54 years
Role:
Director
Appointed:
01/09/2018
Nationality:
British
Age:
54 years
Role:
General Manager
Appointed:
26/04/2018
Nationality:
Swiss
Age:
53 years
Role:
Chief Technology Officer
Appointed:
06/02/2012
Nationality:
British
Age:
65 years
Role:
Chief Executive
Appointed:
01/07/2010
Nationality:
British
Age:
56 years
People with Significant Control
| Name | Nature of Control | Notified On | Nationality | |
|---|---|---|---|---|
| No active PSCs found | ||||
No active PSCs found
Financial Accounts
| Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|
| Income Statement | |||
| Turnover | |||
| Export Revenue | |||
| Sales | |||
| Other Operating Income | |||
| Other Operating Items | |||
| Cost of Sales | |||
| Raw Materials & Consumables | |||
| Gross Profit | |||
| Admin Expenses | |||
| Other Operating Charges | |||
| Depreciation | |||
| R&D Expenses | |||
| Operating Profit | |||
| EBITDA | |||
| Financial Revenue | |||
| Financial Expenses | |||
| Financial Profit/Loss | |||
| Interest Paid | |||
| Extraordinary Revenue | |||
| Extraordinary Expenses | |||
| Net Extraordinary Items | |||
| Pre-Tax Profit | |||
| Tax | |||
| Profit After Tax | |||
| Retained Profit | |||
| Balance Sheet | |||
| Non-Current Assets | |||
| Intangible Assets | |||
| Tangible Fixed Assets | |||
| Other Non-Current Assets | |||
| Current Assets | |||
| Stock | |||
| Debtors | |||
| Cash in Hand | |||
| Other Current Assets | |||
| Called Up Share Capital | |||
| P&L Account Reserve | |||
| Shareholder Funds | |||
| Other Shareholder Funds | |||
| Provisions | |||
| Long Term Debt | |||
| Creditors (> 1 year) | |||
| Other Non-Current Liabilities | |||
| Short Term Debt | |||
| Creditors | |||
| Creditors (< 1 year) | |||
| Other Current Liabilities | |||
| Key Metrics | |||
| Net Assets | |||
| Net Current Assets | |||
| Total Assets Less Current Liabilities | |||
| Working Capital | |||
| Enterprise Value | |||
| Added Value | |||
| Cashflow Before D&A | |||
| Other Information | |||
| Staff Costs | |||
| Number of Employees | |||
Charges
No charges registered
Properties
2 properties
Regions
2
Freehold
1
Leasehold
1
YORKS AND HUMBER
Cowick Hall, Snaith, Goole (DN14 9AA)
Freehold • DN14 9AA
Added 28/07/2005 • EAST RIDING OF YORKSHIRE
GREATER LONDON
Flat 42, Queen Court, Queen Square, (WC1N 3BB)
Leasehold • WC1N 3BB
Added 25/01/2001 • CAMDEN
Grants
Total grant funding received: £4,281.60
| Programme | |||
|---|---|---|---|
| 01/04/2022 | £4,281.60 | Department for Business, Energy and Industrial Strategy | UKRI - Innovate UK - Scheme 22/23 |
| Full Grant details (including summaries) can be found on the Gateway to Research website: https://gtr.ukri.org/projects?ref=511694 | |||
Department for Business, Energy and Industrial Strategy
£4,281.60Full Grant details (including summaries) can be found on the Gateway to Research website: https://gtr.ukri.org/projects?ref=511694
Date Awarded:
01/04/2022
Programme:
UKRI - Innovate UK - Scheme 22/23
Government Council Contracts Beta
No council contracts found
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 15/04/2025 | Confirmation Statement | Confirmation Statement With No Updates | View (3 pages) |
| 04/04/2025 | Officers | Appoint Person Director Company With Name Date | View (2 pages) |
| 03/03/2025 | Officers | Termination Director Company With Name Termination Date | View (1 page) |
| 08/08/2024 | Officers | Change Person Director Company With Change Date | View (2 pages) |
| 25/06/2024 | Officers | Appoint Person Director Company With Name Date | View (2 pages) |
| 28/05/2024 | Officers | Termination Director Company With Name Termination Date | View (1 page) |
| 10/05/2024 | Accounts | Accounts With Accounts Type Group | View (210 pages) |